376 related articles for article (PubMed ID: 28701950)
1. Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer's Disease, But Has Similar Diagnostic Accuracy to Aβ42.
Lauridsen C; Sando SB; Møller I; Berge G; Pomary PK; Grøntvedt GR; Salvesen Ø; Bråthen G; White LR
Front Aging Neurosci; 2017; 9():210. PubMed ID: 28701950
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study.
Lauridsen C; Sando SB; Shabnam A; Møller I; Berge G; Grøntvedt GR; Bakken IJ; Salvesen Ø; Bråthen G; White LR
Front Aging Neurosci; 2016; 8():30. PubMed ID: 26973507
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.
Almdahl IS; Lauridsen C; Selnes P; Kalheim LF; Coello C; Gajdzik B; Møller I; Wettergreen M; Grambaite R; Bjørnerud A; Bråthen G; Sando SB; White LR; Fladby T
Front Aging Neurosci; 2017; 9():9. PubMed ID: 28223932
[No Abstract] [Full Text] [Related]
4. Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.
Janelidze S; Hertze J; Zetterberg H; Landqvist Waldö M; Santillo A; Blennow K; Hansson O
Ann Clin Transl Neurol; 2016 Jan; 3(1):12-20. PubMed ID: 26783546
[TBL] [Abstract][Full Text] [Related]
5. Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions.
Teitsdottir UD; Jonsdottir MK; Lund SH; Darreh-Shori T; Snaedal J; Petersen PH
Alzheimers Res Ther; 2020 Aug; 12(1):92. PubMed ID: 32753068
[TBL] [Abstract][Full Text] [Related]
6. Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression.
Pelkmans W; Shekari M; Brugulat-Serrat A; Sánchez-Benavides G; Minguillón C; Fauria K; Molinuevo JL; Grau-Rivera O; González Escalante A; Kollmorgen G; Carboni M; Ashton NJ; Zetterberg H; Blennow K; Suarez-Calvet M; Gispert JD;
Alzheimers Dement; 2024 Jan; 20(1):483-493. PubMed ID: 37690071
[TBL] [Abstract][Full Text] [Related]
7. Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.
Benedet AL; Milà-Alomà M; Vrillon A; Ashton NJ; Pascoal TA; Lussier F; Karikari TK; Hourregue C; Cognat E; Dumurgier J; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; Salvadó G; Shekari M; Operto G; Gispert JD; Minguillon C; Fauria K; Kollmorgen G; Suridjan I; Zimmer ER; Zetterberg H; Molinuevo JL; Paquet C; Rosa-Neto P; Blennow K; Suárez-Calvet M;
JAMA Neurol; 2021 Dec; 78(12):1471-1483. PubMed ID: 34661615
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic value of CSF amyloid-β(43) in differentiation of dementia syndromes.
Bruggink KA; Kuiperij HB; Claassen JA; Verbeek MM
Curr Alzheimer Res; 2013 Dec; 10(10):1034-40. PubMed ID: 24156268
[TBL] [Abstract][Full Text] [Related]
9. Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.
Deming Y; Black K; Carrell D; Cai Y; Del-Aguila JL; Fernandez MV; Budde J; Ma S; Saef B; Howells B; Bertelsen S; Huang KL; Sutphen CL; Tarawneh R; Fagan AM; Holtzman DM; Morris JC; Goate AM; Dougherty JD; Cruchaga C
BMC Neurol; 2016 Nov; 16(1):217. PubMed ID: 27832767
[TBL] [Abstract][Full Text] [Related]
10. Current Biomarkers for Alzheimer's Disease: From CSF to Blood.
Zou K; Abdullah M; Michikawa M
J Pers Med; 2020 Aug; 10(3):. PubMed ID: 32806668
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
13. Association of
Shang L; Dong L; Huang X; Wang T; Mao C; Li J; Wang J; Liu C; Gao J
Front Aging Neurosci; 2023; 15():1119070. PubMed ID: 37065463
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease.
Antonell A; Mansilla A; Rami L; Lladó A; Iranzo A; Olives J; Balasa M; Sánchez-Valle R; Molinuevo JL
J Alzheimers Dis; 2014; 42(3):901-8. PubMed ID: 25024322
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies.
van Steenoven I; van der Flier WM; Scheltens P; Teunissen CE; Lemstra AW
Alzheimers Res Ther; 2019 Oct; 11(1):83. PubMed ID: 31601267
[TBL] [Abstract][Full Text] [Related]
16. High burdens of phosphorylated tau protein and distinct precuneus atrophy in sporadic early-onset Alzheimer's disease.
Lv X; Cheng Z; Wang Q; Gao F; Dai L; Du C; Liu C; Xie Q; Shen Y; Shi J;
Sci Bull (Beijing); 2023 Nov; 68(22):2817-2826. PubMed ID: 37919158
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
Sutphen CL; Jasielec MS; Shah AR; Macy EM; Xiong C; Vlassenko AG; Benzinger TL; Stoops EE; Vanderstichele HM; Brix B; Darby HD; Vandijck ML; Ladenson JH; Morris JC; Holtzman DM; Fagan AM
JAMA Neurol; 2015 Sep; 72(9):1029-42. PubMed ID: 26147946
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
[TBL] [Abstract][Full Text] [Related]
19. Glial activation and inflammation along the Alzheimer's disease continuum.
Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults.
Paternicò D; Galluzzi S; Drago V; Bocchio-Chiavetto L; Zanardini R; Pedrini L; Baronio M; Amicucci G; Frisoni GB
Alzheimers Dement; 2012 Nov; 8(6):520-7. PubMed ID: 22677492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
